Growth Metrics

Cardlytics (CDLX) Liabilities and Shareholders Equity (2017 - 2025)

Historic Liabilities and Shareholders Equity for Cardlytics (CDLX) over the last 9 years, with Q3 2025 value amounting to $292.8 million.

  • Cardlytics' Liabilities and Shareholders Equity fell 2668.7% to $292.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year decrease of 3183.34%. This contributed to the annual value of $392.7 million for FY2024, which is 3160.06% down from last year.
  • As of Q3 2025, Cardlytics' Liabilities and Shareholders Equity stood at $292.8 million, which was down 2668.7% from $361.1 million recorded in Q2 2025.
  • Cardlytics' 5-year Liabilities and Shareholders Equity high stood at $1.3 billion for Q4 2021, and its period low was $292.8 million during Q3 2025.
  • Over the past 5 years, Cardlytics' median Liabilities and Shareholders Equity value was $634.9 million (recorded in 2023), while the average stood at $750.9 million.
  • As far as peak fluctuations go, Cardlytics' Liabilities and Shareholders Equity skyrocketed by 57355.43% in 2021, and later crashed by 4530.48% in 2022.
  • Cardlytics' Liabilities and Shareholders Equity (Quarter) stood at $1.3 billion in 2021, then plummeted by 45.3% to $691.2 million in 2022, then dropped by 16.94% to $574.1 million in 2023, then tumbled by 31.6% to $392.7 million in 2024, then fell by 25.44% to $292.8 million in 2025.
  • Its last three reported values are $292.8 million in Q3 2025, $361.1 million for Q2 2025, and $369.1 million during Q1 2025.